Relationships between holmium laser enucleation of the prostate and prostate cancer
MS Lee, MA Assmus, J Guo, MR Siddiqui… - Nature Reviews …, 2023 - nature.com
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for
treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with …
treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with …
The Role of Transurethral BPH Surgeries in Management of Urinary Symptoms in Prostate Cancer Patients, Narrative Review
Abstract Purpose of Review Prostate cancer and benign prostate hyperplasia (BPH) are two
ubiquitous pathologies that may coexist. A significant percentage of patients with different …
ubiquitous pathologies that may coexist. A significant percentage of patients with different …
The impact of palliative transurethral resection of the prostate on the prognosis of patients with bladder outlet obstruction and metastatic prostate cancer: a population …
K Fang, P Song, J Zhang, L Yang, P Liu, N Lu… - Frontiers in …, 2021 - frontiersin.org
Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet
obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative …
obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative …
Palliative transurethral resection of the prostate in patients with metastatic prostate cancer: a prospective study of 188 patients
M Qu, F Zhu, H Chen, B Lian, Z Jia, Z Shi, J Li… - Journal of …, 2019 - liebertpub.com
Purpose: Palliative transurethral resection of the prostate (pTURP) in metastatic prostate
cancer (mPCa) is reported to be rarely applied in clinics. We prospectively evaluated the …
cancer (mPCa) is reported to be rarely applied in clinics. We prospectively evaluated the …
Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet …
Y Shi, T Cao, J Xu, D Cui, X Wang, Y Zhu… - Lasers in Medical …, 2023 - Springer
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction
(BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with …
(BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with …
[HTML][HTML] Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates
Abstract Objective Prostate cancer (PCa) patients might experience lower urinary tract
symptoms as those diagnosed with benign prostatic hyperplasia (BPH). Some of them might …
symptoms as those diagnosed with benign prostatic hyperplasia (BPH). Some of them might …
Indications and complications of androgen deprivation therapy
CD Fankhauser, MS Wettstein, M Reinhardt… - Seminars in oncology …, 2020 - Elsevier
Objective To review the indications for and side effects of androgen deprivation therapy
(ADT) in men affected by prostate cancer. Data Sources National guidelines, evidence …
(ADT) in men affected by prostate cancer. Data Sources National guidelines, evidence …
A case of rapidly progressive prostate cancer with bone and lymph node metastasis after contact laser vaporization for benign prostatic hyperplasia
K Muraoka, A Fujisaki, K Uchida, Y Hakamata… - IJU Case …, 2025 - Wiley Online Library
Introduction Prostate cancer is incidentally diagnosed in 6%–11% of benign prostatic
hyperplasia surgeries. Case presentation A 79‐year‐old man was diagnosed with benign …
hyperplasia surgeries. Case presentation A 79‐year‐old man was diagnosed with benign …
[HTML][HTML] Clinical and histopathological characteristics of prostate cancer patients taken to palliative transurethral prostate resection
JP Rojas-Manrique, AR Ramírez, LMB Méndez… - Cureus, 2019 - ncbi.nlm.nih.gov
Methods An observational, descriptive and retrospective study of patients with PCa who
underwent palliative TURP for the relief of obstructive urinary symptoms at an oncology …
underwent palliative TURP for the relief of obstructive urinary symptoms at an oncology …
Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
K **, S Qiu, XY Liao, XN Zheng, X Tu… - Asian Journal of …, 2020 - journals.lww.com
Biochemical recurrence (BCR) is important for measuring the oncological outcomes of
patients who undergo radical prostatectomy (RP). Whether transurethral resection of the …
patients who undergo radical prostatectomy (RP). Whether transurethral resection of the …